Phase I/II study of IMA950 peptide vaccine with Poly-ICLC in combination with standard therapy in newly diagnosed A2 glioblastoma: Preliminary results

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 26; p. viii1
Main Authors Migliorini, D., Dutoit, V., Walker, P.R., Dietrich, P.-Y.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.11.2015
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdv513.06